NewAmsterdam Pharma Company N.V. Share Price Nasdaq
Equities
NAMS
NL00150012L7
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.75 USD | +0.41% |
|
+15.43% | +76.81% |
Sales 2024 * | 8.64M 9.23M 771M | Sales 2025 * | 6.31M 6.75M 564M | Capitalization | 1.66B 1.78B 149B |
---|---|---|---|---|---|
Net income 2024 * | -210M -224M -18.75B | Net income 2025 * | -139M -149M -12.41B | EV / Sales 2024 * | 193 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 264 x |
P/E ratio 2024 * |
-7.91
x | P/E ratio 2025 * |
-12.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 week | +15.43% | ||
Current month | +5.33% | ||
1 month | +4.94% | ||
3 months | -13.07% | ||
6 months | +73.40% | ||
Current year | +76.81% |
![Extreme 16.89](/images/extremecours_fleche.png)
![Extreme 16.6201](/images/extremecours_fleche.png)
Date | Price | Change |
---|---|---|
26/24/26 | 19.75 | +0.41% |
25/24/25 | 19.67 | +0.20% |
24/24/24 | 19.63 | +8.93% |
21/24/21 | 18.02 | +4.59% |
20/24/20 | 17.23 | +0.70% |
Delayed Quote Nasdaq, June 27, 2024 at 01:30 am IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+21.73% | 116B | |
+22.18% | 27.03B | |
-21.81% | 20.36B | |
-16.89% | 16.43B | |
-18.81% | 15.91B | |
-44.74% | 15.6B | |
+62.72% | 14.94B | |
+3.09% | 13.59B |
- Stock Market
- Equities
- NAMS Stock
- NAMS Stock